Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Biliary Tract Cancer Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Biliary Tract Cancer clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Hepatocellular Carcinoma Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Hepatocellular Carcinoma clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Gastric and GEJ Cancer Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Gastric and GEJ Cancer clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Pancreatic Ductal Adenocarcinoma Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Pancreatic Ductal Adenocarcinoma clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white…
Latest Hotspot
8 min read
Metastatic Colorectal Cancer Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Metastatic Colorectal Cancer clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
HR-Positive Breast Cancer Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 HR-Positive Breast Cancer clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
8 min read
HER2-Low Breast Cancer Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 HER2-Low Breast Cancer clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Triple-Negative Breast Cancer Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Triple-Negative Breast Cancer clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white…
Latest Hotspot
8 min read
Small Cell Lung Cancer Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Small Cell Lung Cancer clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Exelixis Company BD Opportunity Scan Report 2026: Pipeline, Deals, Partnering Shortlist, and Outreach Priorities
16 July 2026
Exelixis 2026 BD opportunity scan: pipeline assets, transaction precedents, financial signals, IP-risk flags, and a prioritized partnering shortlist.
Latest Hotspot
8 min read
Ionis Pharmaceuticals Company BD Opportunity Scan Report 2026: Pipeline, Deals, Partnering Shortlist, and Outreach Priorities
16 July 2026
Ionis Pharmaceuticals 2026 BD opportunity scan: pipeline assets, transaction precedents, financial signals, IP-risk flags, and a prioritized partnering shortlist.
Latest Hotspot
8 min read
Ultragenyx Pharmaceutical Company BD Opportunity Scan Report 2026: Pipeline, Deals, Partnering Shortlist, and Outreach Priorities
16 July 2026
Ultragenyx Pharmaceutical 2026 BD opportunity scan: pipeline assets, transaction precedents, financial signals, IP-risk flags, and a prioritized partnering shortlist.